Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Lymphoid × Doxorubicin × Clear all

Sponsor

Conditions

Breast Neoplasms 89 Lymphoma 58 Lymphoma, Large B-Cell, Diffuse 43 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Sarcoma 31 Lymphoma, Non-Hodgkin 27 Hodgkin Disease 23 Leukemia 20 Burkitt Lymphoma 20 Lymphoma, Mantle-Cell 18 Neoplasms 16 Triple Negative Breast Neoplasms 14 Lymphoma, Follicular 14 Lymphoma, B-Cell 12 Carcinoma, Hepatocellular 12 Lymphoma, Large-Cell, Anaplastic 11 Neuroblastoma 10 Multiple Myeloma 10 Breast Neoplasms, Male 10 Neoplasm Metastasis 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Ovarian Neoplasms 8 Lymphoma, T-Cell, Peripheral 7 Lymphoma, T-Cell 7 Inflammatory Breast Neoplasms 7 Urinary Bladder Neoplasms 6 Osteosarcoma 6 Liposarcoma 6 Leiomyosarcoma 6 Fallopian Tube Neoplasms 6

Interventions

ibrutinib 4 Rituximab 4 fludarabine phosphate 3 fludarabine 3 Bendamustine Hydrochloride 3 blinatumomab 2 Melphalan 2 Lenalidomide 2 Busulfan 2 Alemtuzumab 2 thymoglobulin 1 pirtobrutinib 1 ofatumumab 1 obinutuzumab 1 lirilumab 1 copanlisib 1 RFT5-SMPT-dgA immunotoxin 1 Leukapheresis 1 Immunotherapy, Adoptive 1 Everolimus 1 Cyclophosphamide 1 CT-P10 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡